ArticleHepatology communications2026
Radioembolization (90Y) achieves higher response rates and reduces progression risk compared with DEB-TACE in hepatocellular carcinoma.
Kelley Núñez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.